accountIn its mid-2006 initial public offering prospectus, Louisville, Colo.-based Replidyne had said Orapem might need additional trials to support approval (Pharmaceutical Approvals Monthly July 2006, p. 3)....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Forest/Replidyne Orapem collaboration is no more
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account